Abstract HIV-associated lipodystrophy (HIV-LD) is characterized by a loss of adipose tissue
from the subcutaneous compartment. Previously reported data suggested that this loss of …

Background Combined use of dual-energy X-ray absorptiometry (DXA) and magnetic
resonance imaging (MRI) allows a precise estimate of regional body composition and intra …

Background Abnormal levels of tumour necrosis factor (TNF)-α, interleukin (IL)-6 and
adiponectin have been observed in HIV patients with lipodystrophy. However, because …

In developed countries, the availability of highly active antiretroviral therapy (HAART) has
contributed to a dramatic decrease in mortality and opportunistic infections associated with …

Objectives: Identify the etiology of HIV-associated lipodystrophy. Describe the typical
physical exam of a patient with HIV-associated lipoatrophy. Review the treatment and …

The pathogenesis of lipodystrophy in HIV-infected patients is likely multifactorial, involving
effects of antiretroviral medications, HIV itself, as well as genetic and other host factors …

Background Lipodystrophies are characterized by adipose tissue redistribution, insulin
resistance (IR) and metabolic complications. Adipokines and hormones related to body …

Human lipodystrophies are a heterogeneous group of diseases characterized by
generalized or partial fat loss. If localized, they are often associated with fat hypertrophy in …

Background Fat abnormalities are common among HIV-infected persons, but few studies
have compared regional body fat distribution, including visceral fat, in HIV-infected and HIV …

HIV-associated lipodystrophy syndrome, also known as fat redistribution syndrome, is an
only recently described disorder consisting of changes in body fat distribution, metabolic …